Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$77,000.00

Microfluidic Chain Reaction: Exploration, Expansion, and Application

FY 2024-25

Summary
Microfluidic Chain Reaction: Exploration, Expansion, and Application Ultrasensitive immunoassays reveal hitherto undetectable features, and are poised to advance early diagnosis and monitoring of COVID19, HIV, neurological disease and injury, and cancer. Their impact would be greatest at the point-of-care (POC), but they remain dependent on complex instrumentation housed in laboratories, and are stifled by a trade-off between assay performance and time-to-result. We propose to study and develop two lab discoveries: Microfluidic chain reactions (MCRs) and Brownian affinity trap (BAT) arrays, and integrate them on 3D printed capillary microfluidic chips for minimally instrumented, ultrasensitive (zeptomolar), and fast (<30 min) POC testing. We previously introduced capillaric circuits (CCs) that use capillary phenomena to (i) execute up to 8 fluidic operations structurally encoded in the surface microarchitecture, and (ii) for pumping. We recently discovered MCR that introduce conditional, event-based programmability (i.e. chain reaction), and enable MCR-CCs to encode, and autonomously execute, complex algorithms (300 steps) previously requiring a computer. The BAT is a microscopic pore coated with antibodies, and traps target molecules flowing through it because of Brownian motion induced wall collisions and affinity binding. The Overall goal is to explore the MCR and the BAT, and combine them for a minimally instrumented, ultrasensitive, rapid, POC test. Aim 1: MCR Exploration, Extension and Complementation CCs and the MCR are restricted to high surface tension aqueous solutions that can `decode' the structurally encoded fluidic operations. We propose to extend CCs to low surface tensions liquids using indirect valving with aqueous solutions, and 3D printed capillary `super' valves. MCR was realized using negative pressure. We will design positive pressure MCR, and complementary n-p MCR. We will encode DNA extraction and drug screening in MCR-CCs as a proof-of-concept. Aim 2: The Brownian Affinity Trap (BAT) and its use for digital ELISA Ultrasensitive digital ELISA (dELISA) use bead encapsulation, and each bead is read out as a "0", or in case of single molecule binding a "1". We will study computationally and experimentally the BAT. Samples will be flowed through arrays of millions of BATs, and single molecule binding events detected. We predict that BAT dELISA will be more sensitive and much faster. Aim 3: Digital additive manufacturing of MCRs and BATs for POC diagnostics MCRs can readily be 3D printed, but are hydrophobic. We introduce new hydrophilic resins for direct (i.e. digital) manufacturing of MCR-CCs (incl. BATs), for distributed manufacturing with collaborators. Significance MCR-CCs could become to microfluidics what cell phones (portable computers) are to desktop computers, while they could be home-built using a $500 3D printer, and used to make ultrasensitive, rapid, point-of-care diagnostics thanks to BAT arrays.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2022-05171
Name nom
Juncker, David
Department département
Biomedical Engineering - Biomedical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
77000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Microfluidic Chain Reaction: Exploration, Expansion, and Application
Keywords
lab-on-a-chip; capillary microfluidics; chain reactions; immunoassays; digital assays; ultrasensitive assays; single molecule detection; microfilter channel arrays; point-of-care tests; digital manufacturing by 3d printing
Application summary
Microfluidic Chain Reaction: Exploration, Expansion, and Application Ultrasensitive immunoassays reveal hitherto undetectable features, and are poised to advance early diagnosis and monitoring of COVID19, HIV, neurological disease and injury, and cancer. Their impact would be greatest at the point-of-care (POC), but they remain dependent on complex instrumentation housed in laboratories, and are stifled by a trade-off between assay performance and time-to-result. We propose to study and develop two lab discoveries: Microfluidic chain reactions (MCRs) and Brownian affinity trap (BAT) arrays, and integrate them on 3D printed capillary microfluidic chips for minimally instrumented, ultrasensitive (zeptomolar), and fast (<30 min) POC testing. We previously introduced capillaric circuits (CCs) that use capillary phenomena to (i) execute up to 8 fluidic operations structurally encoded in the surface microarchitecture, and (ii) for pumping. We recently discovered MCR that introduce conditional, event-based programmability (i.e. chain reaction), and enable MCR-CCs to encode, and autonomously execute, complex algorithms (300 steps) previously requiring a computer. The BAT is a microscopic pore coated with antibodies, and traps target molecules flowing through it because of Brownian motion induced wall collisions and affinity binding. The Overall goal is to explore the MCR and the BAT, and combine them for a minimally instrumented, ultrasensitive, rapid, POC test. Aim 1: MCR Exploration, Extension and Complementation CCs and the MCR are restricted to high surface tension aqueous solutions that can `decode' the structurally encoded fluidic operations. We propose to extend CCs to low surface tensions liquids using indirect valving with aqueous solutions, and 3D printed capillary `super' valves. MCR was realized using negative pressure. We will design positive pressure MCR, and complementary n-p MCR. We will encode DNA extraction and drug screening in MCR-CCs as a proof-of-concept. Aim 2: The Brownian Affinity Trap (BAT) and its use for digital ELISA Ultrasensitive digital ELISA (dELISA) use bead encapsulation, and each bead is read out as a "0", or in case of single molecule binding a "1". We will study computationally and experimentally the BAT. Samples will be flowed through arrays of millions of BATs, and single molecule binding events detected. We predict that BAT dELISA will be more sensitive and much faster. Aim 3: Digital additive manufacturing of MCRs and BATs for POC diagnostics MCRs can readily be 3D printed, but are hydrophobic. We introduce new hydrophilic resins for direct (i.e. digital) manufacturing of MCR-CCs (incl. BATs), for distributed manufacturing with collaborators. Significance MCR-CCs could become to microfluidics what cell phones (portable computers) are to desktop computers, while they could be home-built using a $500 3D printer, and used to make ultrasensitive, rapid, point-of-care diagnostics thanks to BAT arrays.